Reply to Soteriadou et al

Affiliations

¹ 1Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 2Department of Internal Medicine, Division of Gastroenterology and Hepatology, William Beaumont Hospital, Royal Oak, Michigan 3Department of Internal Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota.

Comment

Maneesh Dave et al. Inflamm Bowel Dis. 2014 Feb.

. 2014 Feb;20(2):E5-6.

doi: 10.1097/01.MIB.0000438431.23176.5d.

¹ 1Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 2Department of Internal Medicine, Division of Gastroenterology and Hepatology, William Beaumont Hospital, Royal Oak, Michigan 3Department of Internal Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota.

No abstract available

Comment on

Opportunistic infections due to inflammatory bowel disease therapy.
Dave M, Purohit T, Razonable R, Loftus EV Jr. Dave M, et al. Inflamm Bowel Dis. 2014 Jan;20(1):196-212. doi: 10.1097/MIB.0b013e3182a827d2. Inflamm Bowel Dis. 2014. PMID: 24051931 Review.
The "Q" of fever in inflammatory bowel disease.
Soteriadou S, Blanchard T, Limdi JK. Soteriadou S, et al. Inflamm Bowel Dis. 2014 Feb;20(2):E4-5. doi: 10.1097/01.MIB.0000438426.41102.12. Inflamm Bowel Dis. 2014. PMID: 24374882 No abstract available.